Influence of 1 and 25 Hz, 1.5 mT Magnetic Fields on Antitumor Drug Potency in a Human Adenocarcinoma Cell Line

Bioelectromagnetics

Volumn 23, Issue 8, 2002, Pages 578-525

  Ruiz Gomez M J ^a   De La Pena L ^a   Prieto Barcia, M I ^a   Pastor, J M ^a   Gil, L ^a   Martinez Morillo M ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Antitumor agents; Drug resistance; Human colon adenocarcinoma; PEMF; Pulsed electromagnetic fields

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; DRUG DOSAGE; ELECTROMAGNETIC FIELDS;

ADENOCARCINOMA CELLS; ANTITUMOUR AGENTS; CELL LINES; DRUG-RESISTANCE; ELECTROMAGNETIC FIELD EXPOSURE; HUMAN COLON; HUMAN COLON ADENOCARCINOMA; MITOMYCIN C; PULSED ELECTROMAGNETIC FIELDS;

CELLS;

ANTINEOPLASTIC AGENT; CISPLATIN; MITOMYCIN; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG POTENCY; ELECTRIC CURRENT; HUMAN; HUMAN CELL; IN VITRO STUDY; MAGNETIC FIELD; PRIORITY JOURNAL; PULSED ELECTRIC FIELD; ADENOCARCINOMA; APOPTOSIS; CELL CULTURE; CELL DIVISION; COLON TUMOR; COMPARATIVE STUDY; DOSE RESPONSE; ELECTROMAGNETIC FIELD; MAGNETISM; MULTIDRUG RESISTANCE; PATHOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TIME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CISPLATIN; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE, MULTIPLE; ELECTROMAGNETIC FIELDS; HUMANS; MAGNETICS; MITOMYCIN; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 2442621311     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/bem.10054     Document Type: Article

References (22)

1. Babich H, Rosenberg DW, Borenfreund E. 1991. In vitro cytotoxicity studies with the fish hepatoma cell line, PLHC-1 (Poeciliopsis lucida). Ecotox Environ Safe 21:327-336.
2. Bassen H, Litovitz T, Penafiel M, Meister R. 1992. ELF in vitro exposure systems for inducing uniform electric and magnetic fields in cell culture media. Bioelectromagnetics 13:183-198.
3. Conti P, Gigante GE, Alesse E, Cifone MG, Fieschi C, Reale M, Angeletti PU. 1985. Effect of electromagnetic fields on two calcium dependent biological systems. J Bioelectricity 4:227-236.
4. Fautz R, Husein B, Hechenberger C. 1991. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: Rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat Res 253:173-179.
5. Florez J, Armijo JA, Mediavilla A. 1997. Farmacología humana. Barcelona: Masson SA (third edition).
6. Hannan CJ, Liang Y, Allison JD, Searle JR. 1994. In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. Anticancer Res 14:1517-1520.
7. Harland JD, Liburdy RP. 1997. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18:555-562.
8. Hofmann GA, Dev SB, Dimmer S, Nanda GS. 1999. Electroporation therapy: A new approach for the treatment of head and neck cancer. IEEE Trans Biomed Eng 46:752-759.
9. Kang Y, Perry RR. 1994. Effect of a-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. Cancer Res 54:2952-2958.
10. R-8-5-11 by a pulsed magnetic field. Anticancer Res 17:2083-2088.
11. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. 1998. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74:2152-2158.
12. Miyagi N, Sato K, Rong Y, Yamamura S, Katagiri H, Kobayashi K, Iwata H. 2000. Effects of PEMF on a murine osteosarcoma cell line: drug-resistant (P-glycoprotein-positive) and non-resistant cells. Bioelectromagnetics 21:112-121.
13. Morales JA, Ruiz-Gómez MJ, Gil-Carmona L, Souviron A, Martínez-Morillo M. 1995. He-Ne laser has no effect on cell cycle phases of human colon adenocarcinoma cells. Rev Esp Fisiol (J Physiol Biochem) 51(1):43-48.
14. Morgan CD, Mills KC, Lefkowitz DL, Lefkowitz SS. 1991. An improved colorimetric assay for tumor necrosis factor using WEHI 164 cells cultured on novel microtiter plates. J Immunol Methods 145:259-262.
15. Murthy SN. 1999. Magnetophoresis: An approach to enhance transdermal drug diffusion. Pharmazie 54(5):377-379.
16. Omote Y. 1988. An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents. Jpn Surg Soc 89:1155-1166.
17. Omote Y, Hosokawa M, Komastsumoto M, Namieno T, Nakjima S, Kubo Y, Kobayashi H. 1990. Treatment of experimental tumors with a combination of a pulsing magnetic field and anti-tumor drug. Jpn J Cancer Res 81:956-961.
18. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi G. 1993. Biological effects of PEMF (pulsing electromagnetic fields): An attempt to modify cell resistance to anticancer agents. J Environmental Pathol Toxicol Oncol 12(4):193-197.
19. Ruiz Gómez MJ, Pastor Vega JM, de la Peña L, Gil Carmona L, Martínez Morillo M. 1999. Growth modification of human colon adenocarcinoma cells exposed to a low-frequency electromagnetic field. J Physiol Biochem 55(2):79-84.
20. Ruiz Gómez MJ, Gil L, Souviron A, Martínez Morillo M. 2000. Multidrug resistance increment in a human colon carcinoma cell line by colchicine. J Physiol Biochem 56(1):33-38.
21. Souviron Rodríguez A, Ruiz Gómez MJ, Morales Moreno JA, Martínez Morillo M. 1997. Multirresistencia a drogas (MDR) en oncología. An Med Intern 14:145-153.
22. Weaver JC, Astumian RD. 1990. The response of living cells to very weak electric fields: The thermal noise limit. Science 247: 459-462.